生物分析検査サービスの世界市場

Report Overview

The global bioanalytical testing services market reached $2.9 billion in 2022, should reach $3.2 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023-2028.

Summary:

The global pharmaceutical market is expected to expand further as the global economy grows, the global population increases, the ageing population grows, technology advances, healthcare expenditures rise, and public health awareness grows. Further, pharmaceutical research and production is predicted to continue growing rapidly, owing to increased outsourcing in major pharmaceutical corporations and increased demand from small and medium pharmaceutical enterprises. Because new drug development R&D has significant investment, a long cycle, and a high risk, large pharmaceutical businesses are required to promote R&D projects through external R&D institutes in order to increase
R&D efficiency and minimize R&D expenses as a result of low R&D returns and the “patent cliff” faced by drug producers.

Small and medium pharmaceutical as well as biotechnology firms, virtual enterprises, and individual entrepreneurs, have emerged as a key driving force in pharmaceutical innovation. These small and medium pharmaceutical enterprises lack the time and budget to establish the laboratory and manufacturing facilities required for their own R&D projects, but they require a variety of services to satisfy the demands of R&D projects in a timely manner. As a result, they will seek R&D and production outsourcing services, particularly integrated end-to-end R&D services, to suit their R&D service requirements ranging from idea validation through product launch, thus driving the bioanalytical testing services market.

Bioanalytical testing is crucial for developing new drugs. Pharmacokinetics and toxicology studies are assessed using bioanalytical techniques to measure medicines and their metabolites or biomarkers in biological fluids. These techniques can be used to research human clinical toxicity and pharmacology. The most important aspect during drug development is comprehending the drug concentration after injection or consumption. Drug concentration affects a drug’s bioavailability and effects throughout that time. The drug won’t have the expected effects if the concentration is too low, while the system may become toxic if the concentration is too high.

Report Scope:

The report’s scope includes an overview of the global market on bioanalytical testing services and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.

The report analyzes leading services, applications, end user, and product details for the bioanalytical testing services market. Leading market players’ profiles, specific services, financial information, and recent market activities are provided. This report also assesses companies’ mergers & acquisitions and funding activities and their impact in the face of the competitive environment. The report details the bioanalytical testing services market based on service type, application, and end user. The market is segmented into pharmacokinetics studies, bioequivalence and bioavailability studies, biomarker testing services, cell-based assays, virology testing, method development, optimization & validation, serology, immunogenicity, and neutralizing antibodies, and others.

The market is categorized as oncology, immunology, neurology, infectious diseases, cardiovascular diseases, and others. The market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, contract development and manufacturing organizations, and others. The report also consists of the impact of the COVID-19 pandemic on this market. Regional analysis includes North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the World (South America, and the Middle East and Africa).

Report Synopsis

Report Includes:

• 45 data tables and 44 additional tables
• An overview of the global market for bioanalytical testing services
• An estimate of market size and analyses of global market trends, with data from 2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2028
• Characterization and quantification of the global market for bioanalytical testing services on the basis of technology, application, end user and region
• Information on sample requirements for discovery bioanalysis, preclinical and clinical bioanalysis and descriptions of toxicokinetic and pharmacokinetics studies
• Coverage of technological advances in the drug discovery process and information on investments in the R&D of biologics, biosimilars and other specialty drugs
• An examination of the drivers and constraints that will shape the market, and a discussion of the upcoming market opportunities in order to forecast the market by its segments and sub-segments
• An assessment of existing products as well as those in the pipelines of the major players in the market
• Coverage of recent advances, emerging technologies and ongoing developments in the industry
• An evaluation of key industry acquisitions and strategic alliances, and an analysis of the market shares of the leading companies
• Company profiles of major players within the industry, including SGS S.A., Intertek Group PLC, Eurofins Scientific SE, Charles River International Laboratories, Inc., Inotiv Inc., and WuXi AppTec

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Introduction
Technology Background
Liquid Chromatography-Mass Spectrometry (LC-MS)
Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
Nuclear Magnetic Resonance (NMR)
Capillary Electrophoresis (CE)
Gas Chromatography-Mass Spectrometry (GC-MS)
Chapter 4 Market Dynamics
Market Dynamics
Drivers
Restraints
Opportunities
Impact of COVID-19 on the Bioanalytical Testing Services Market
Regulatory Landscape
PESTEL Analysis
Success Factors in Pharmaceutical Bioanalysis
Investing in High Capability Equipment
Constant Evaluation of the Latest Technologies
Considering the Impact of Rising Dose Trials on Patient Safety
Keeping a Track of Changes in Regulatory Environment
Chapter 5 Global Bioanalytical Testing Services Market by Service Type
Pharmacokinetics Studies
Bioequivalence and Bioavailability Studies
Biomarker Testing Services
Cell-Based Assays
Virology Testing
Method Development, Optimization & Validation
Serology, Immunogenicity, and Neutralizing Antibodies
Others
Chapter 6 Global Bioanalytical Testing Services Market by Application
Oncology
Cardiovascular Diseases
Immunology
Neurology
Infectious Diseases
Others
Chapter 7 Global Bioanalytical Testing Services Market by End User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations (CROs)
Contract Development and Manufacturing Organizations (CDMOs)
Others
Chapter 8 Global Bioanalytical Testing Services Market by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 9 ESG Developments
Introduction to ESG
Importance of ESG in Bioanalytical Testing Services Industry
ESG Ratings and Metrics: Understanding the Data
ESG practices in the Bioanalytical Testing Services Industry
Environmental Performance
Social Performance
Governance Performance
Future Trends
BCC Research Viewpoint
Chapter 10 Emerging Technologies and Developments
Emerging Technologies
Recent Developments in Bioanalytical Sample Preparation Techniques
Chapter 11 M&A Analysis
M&A Analysis
Chapter 12 Competitive Intelligence
Top Market Players Ranking, 2022
Key Strategies Adopted by Companies
Expansion
New Product Launch
Collaboration
Others
Chapter 13 Company Profiles
AFFIGENIX BIOSOLUTIONS PVT LTD
ALMAC GROUP
ARAGEN LIFE SCIENCES PVT LTD
BIOANALYTICAL SYSTEMS INC.
BIONEEDS INDIA PRIVATE LTD
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
EUROFINS SCIENTIFIC SE
INOTIV INC. (ENVIGO)
INTERTEK GROUP PLC
LABORATORY CORP. OF AMERICA HOLDINGS
PACE ANALYTICAL
PACIFIC BIOLABS
SARTORIUS AG
SGS S.A.
SYNEOS HEALTH
WUXI APPTEC CO. LTD

List of Tables
Summary Table : Global Market for Bioanalytical Testing Services, by Service Type, Through 2028
Table 1 : Comparison of GC-MS and LC-MS for Trace Analysis of Drugs in Biological Fluids
Table 2 : Market Dynamics: Impact Analysis
Table 3 : Total Number of New Cases and Deaths Due to Various Cancers Globally, 2020
Table 4 : Agencies Responsible for GLP Regulations in Major Countries
Table 5 : Global Market for Bioanalytical Testing Services, by Service Type, Through 2028
Table 6 : Global Market for Bioanalytical Testing Services for Pharmacokinetics Studies, by Region, Through 2028
Table 7 : Global Market for Bioanalytical Testing Services for Bioequivalence and Bioavailability Studies, by Region, Through 2028
Table 8 : Global Market for Bioanalytical Testing Services for Biomarker Testing Services, by Region, Through 2028
Table 9 : Global Market for Bioanalytical Testing Services for Cell-Based Assays, by Region, Through 2028
Table 10 : Global Market for Bioanalytical Testing Services for Virology Testing, by Region, Through 2028
Table 11 : Global Market for Bioanalytical Testing Services for Method Development, Optimization and Validation, by Region, Through 2028
Table 12 : Global Market for Bioanalytical Testing Services for Serology, Immunogenicity, and Neutralizing Antibodies Studies, by Region, Through 2028
Table 13 : Global Market for Bioanalytical Testing Services for Other, by Region, Through 2028
Table 14 : Global Market for Bioanalytical Testing Services, by Application, Through 2028
Table 15 : Global Market for Bioanalytical Testing Services for Oncology, by Region, Through 2028
Table 16 : Global Market for Bioanalytical Testing Services for Cardiovascular Diseases, by Region, Through 2028
Table 17 : Global Market for Bioanalytical Testing Services for Immunology, by Region, Through 2028
Table 18 : Global Market for Bioanalytical Testing Services for Neurology, by Region, Through 2028
Table 19 : Global Market for Bioanalytical Testing Services for Infectious Diseases, by Region, Through 2028
Table 20 : Global Market for Bioanalytical Testing Services for Other, by Region, Through 2028
Table 21 : Global Market for Bioanalytical Testing Services Market, by End User, Through 2028
Table 22 : Global Market for Bioanalytical Testing Services for Pharmaceutical and Biopharmaceutical Companies, by Region, Through 2028
Table 23 : Global Market for Bioanalytical Testing Services for CROs, by Region, Through 2028
Table 24 : Global Market for Bioanalytical Testing Services for CDMOs, by Region, Through 2028
Table 25 : Global Market for Bioanalytical Testing Services for Other, by Region, Through 2028
Table 26 : Global Market for Bioanalytical Testing Services, by Region, Through 2028
Table 27 : North American Market for Bioanalytical Testing Services, by Service Type, Through 2028
Table 28 : North American Market for Bioanalytical Testing Services, by Application, Through 2028
Table 29 : North American Market for Bioanalytical Testing Services, by End User, Through 2028
Table 30 : European Market for Bioanalytical Testing Services, by Service Type, Through 2028
Table 31 : European Market for Bioanalytical Testing Services, by Application, Through 2028
Table 32 : European Market for Bioanalytical Testing Services, by End User, Through 2028
Table 33 : Asia-Pacific Market for Bioanalytical Testing Services, by Service Type, Through 2028
Table 34 : Asia-Pacific Market for Bioanalytical Testing Services, by Application, Through 2028
Table 35 : Asia-Pacific Market for Bioanalytical Testing Services, by End User, Through 2028
Table 36 : Rest of the World Market for Bioanalytical Testing Services, by Service Type, Through 2028
Table 37 : Rest of the World Market for Bioanalytical Testing Services, by Application, Through 2028
Table 38 : Rest of the World Market for Bioanalytical Testing Services, by End User, Through 2028
Table 39 : ESG Ratings and Metrics: Global Bioanalytical Testing Services Market
Table 40 : Environmental Performance: Global Bioanalytical Testing Services Market
Table 41 : Social Performance: Global Bioanalytical Testing Services Market
Table 42 : Governance Performance: Global Bioanalytical Testing Services Market
Table 43 : ESG Rankings for Major Bioanalytical Testing Services Companies, 2023*
Table 44 : Acquisitions in Bioanalytical Testing Services Market, January 2021-May 2023
Table 45 : Expansion: Bioanalytical Testing Services Market, 2020-2023
Table 46 : New Product Launch: Bioanalytical Testing Services Market, 2020-2023
Table 47 : Collaboration Deals: Bioanalytical Testing Services Market, 2023
Table 48 : Other Strategic Alliances: Bioanalytical Testing Services Market, 2021-2023
Table 49 : Affigenix Biosolutions Pvt Ltd: Services Portfolio
Table 50 : Almac Group: News/Developments, 2020-2022
Table 51 : Almac Group: Services
Table 52 : Aragen Life Sciences Pvt Ltd: Annual Revenue, 2022
Table 53 : Aragen Life Sciences Pvt Ltd: News/Developments, 2021-2023
Table 54 : Aragen Life Sciences Pvt Ltd: Services
Table 55 : Bioanalytical Systems Inc.: News/Developments, 2021-2022
Table 56 : Bioanalytical Systems Inc.: Services
Table 57 : Bioneeds India Private Ltd: News/Developments, 2021 and 2022
Table 58 : Bioneeds India Private Ltd: Services
Table 59 : Charles River Laboratories International, Inc.: Financials, 2022
Table 60 : Charles River Laboratories International, Inc.: News/Developments, 2021-2023
Table 61 : Charles River Laboratories International, Inc.: Services
Table 62 : Eurofins Scientific SE: Financials, 2022
Table 63 : Eurofins Scientific SE: News/Developments, 2021-2023
Table 64 : Eurofins Scientific SE: Services
Table 65 : Inotiv, Inc.: Financials, 2022
Table 66 : Inotiv, Inc.: News/Developments, 2021-2023
Table 67 : Inotiv, Inc.: Services
Table 68 : Intertek Group Plc: Financials, 2022
Table 69 : Intertek Group Plc: Services
Table 70 : LabCorp: Financials, 2022
Table 71 : LabCorp: News/Developments, 2021 and 2022
Table 72 : LabCorp: Services
Table 73 : Pace Analytical: News/Developments, 2021 and 2022
Table 74 : Pace Analytical: Services
Table 75 : Pacific BioLabs: News/Developments, 2022 and 2023
Table 76 : Pacific BioLabs: Services
Table 77 : Sartorius AG: Financials, 2022
Table 78 : Sartorius AG: News/Developments, 2020 and 2023
Table 79 : Sartorius AG: Services
Table 80 : SGS S.A.: Financials, 2022
Table 81 : SGS S.A.: News/Developments, 2021 and 2022
Table 82 : SGS S.A.: Services
Table 83 : Syneos Health Inc.: Financials, 2022
Table 84 : Syneos Health Inc.: News/Developments, 2023
Table 85 : Syneos Health Inc.: Services Portfolio
Table 86 : WuXi AppTec Co. Ltd: Financials, 2022
Table 87 : WuXi AppTec Co. Ltd.: News/Developments, 2020-2022
Table 88 : WuXi AppTec Co. Ltd: Services

List of Figures
Summary Figure : Global Market for Bioanalytical Testing Services, by Service Type, 2021-2028
Figure 1 : ICP-MS Trace Metals Analysis Workflow
Figure 2 : NMR Technique in Drug Discovery and Development
Figure 3 : Global Estimated New Cancer Cases, by Region, 2020 vs. 2040
Figure 4 : PESTEL Analysis: Bioanalytical Testing Services Market
Figure 5 : Snapshot of Global Market for Bioanalytical Testing Services, by Service Type, 2021-2028
Figure 6 : Global Market for Bioanalytical Testing Services for Pharmacokinetics Studies, by Region, 2021-2028
Figure 7 : Global Market for Bioanalytical Testing Services for Bioequivalence and Bioavailability Studies, by Region, 2021-2028
Figure 8 : Global Market for Bioanalytical Testing Services for Biomarker Testing Services, by Region, 2021-2028
Figure 9 : Global Market for Bioanalytical Testing Services for Cell-Based Assays, by Region, 2021-2028
Figure 10 : Global Market for Bioanalytical Testing Services for Virology Testing, by Region, 2021-2028
Figure 11 : Global Market for Bioanalytical Testing Services for Method Development, Optimization and Validation, by Region, 2021-2028
Figure 12 : Global Market for Bioanalytical Testing Services for Serology, Immunogenicity, and Neutralizing Antibodies Studies, by Region, 2021-2028
Figure 13 : Global Market for Bioanalytical Testing Services for Other, by Region, 2021-2028
Figure 14 : Snapshot of Global Market for Bioanalytical Testing Services, by Application, 2021-2028
Figure 15 : Global Market for Bioanalytical Testing Services for Oncology, by Region, 2021-2028
Figure 16 : Global Market for Bioanalytical Testing Services for Cardiovascular Diseases, by Region, 2021-2028
Figure 17 : Global Market for Bioanalytical Testing Services for Immunology, by Region, 2021-2028
Figure 18 : Global Market for Bioanalytical Testing Services for Neurology, by Region, 2021-2028
Figure 19 : Global Market for Bioanalytical Testing Services for Infectious Diseases, by Region, 2021-2028
Figure 20 : Global Market for Bioanalytical Testing Services for Other, by Region, 2021-2028
Figure 21 : Snapshot of Global Market for Bioanalytical Testing Services, by End User, 2021-2028
Figure 22 : Global Market for Bioanalytical Testing Services for Pharmaceutical and Biopharmaceutical Companies, by Region, 2021-2028
Figure 23 : Global Market for Bioanalytical Testing Services for CROs, by Region, 2021-2028
Figure 24 : Global Market for Bioanalytical Testing Services for CDMOs, by Region, 2021-2028
Figure 25 : Global Market for Bioanalytical Testing Services for Other, by Region, 2021-2028
Figure 26 : Snapshot of Global Market Values and Shares for Bioanalytical Testing Services, by Region, 2023
Figure 27 : U.S. Elderly (65 and Above) Population, Projections and Trends, 2010-2050
Figure 28 : North American Market for Bioanalytical Testing Services, by Service Type, 2021-2028
Figure 29 : North American Market for Bioanalytical Testing Services, by Application, 2021-2028
Figure 30 : North American Market for Bioanalytical Testing Services, by End User, 2021-2028
Figure 31 : Distribution Share of R&D Investments in Europe, by Function, 2020
Figure 32 : European Market for Bioanalytical Testing Services, by Service Type, 2021-2028
Figure 33 : European Market for Bioanalytical Testing Services, by Application, 2021-2028
Figure 34 : European Market for Bioanalytical Testing Services, by End User, 2021-2028
Figure 35 : Asia-Pacific Market for Bioanalytical Testing Services, by Service Type, 2021-2028
Figure 36 : Asia-Pacific Market for Bioanalytical Testing Services, by Application, 2021-2028
Figure 37 : Asia-Pacific Market for Bioanalytical Testing Services, by End User, 2021-2028
Figure 38 : Rest of the World Market for Bioanalytical Testing Services, by Service Type, 2021-2028
Figure 39 : Rest of the World Market for Bioanalytical Testing Services, by Application, 2021-2028
Figure 40 : Rest of the World Market for Bioanalytical Testing Services, by End User, 2021-2028
Figure 41 : How a Strong ESG Proposition Benefits Businesses
Figure 42 : The Ten Business Sustainability Trends Identified for 2022
Figure 43 : Snapshot – Key ESG Trends in Bioanalytical Testing Services Industry
Figure 44 : Research Communities’ Key Sustainable Practices in Research Laboratories
Figure 45 : Sample Preparation Techniques in Bioanalytics
Figure 46 : M&A in Bioanalytical Testing Services Industry, by Year, 2021-May 2023
Figure 47 : Leading Market Players Ranking, 2022
Figure 48 : Share of Strategies Adopted by Leading Players in the Global Bioanalytical Testing Services Market, Competitive Intelligence, 2020-2023
Figure 49 : Aragen Life Sciences Pvt Ltd: Annual Revenue, 2021 and 2022
Figure 50 : Aragen Life Sciences Pvt Ltd: Revenue Share, by Segment, 2022
Figure 51 : Aragen Life Sciences Pvt Ltd: Revenue Share, by Region, 2022
Figure 52 : Charles River Laboratories International, Inc.: Financials, 2021 and 2022
Figure 53 : Charles River Laboratories International, Inc.: Revenue Share, by Segment, 2022
Figure 54 : Charles River Laboratories International, Inc.: Revenue Share, by Business Unit, 2022
Figure 55 : Charles River Laboratories International, Inc.: Revenue Share, by Region, 2022
Figure 56 : Eurofins Scientific SE: Financials, 2021 and 2022
Figure 57 : Eurofins Scientific SE: Revenue Share, by Segment, 2022
Figure 58 : Eurofins Scientific SE: Revenue Share, by Region, 2022
Figure 59 : Inotiv, Inc.: Financials, 2021 and 2022
Figure 60 : Inotiv, Inc.: Revenue Share, by Segment, 2022
Figure 61 : Inotiv, Inc.: Revenue Share, by Region, 2022
Figure 62 : Intertek Group Plc: Financials, 2021 and 2022
Figure 63 : Intertek Group Plc: Revenue Share, by Segment, 2022
Figure 64 : Intertek Group Plc: Revenue Share, by Product Type, 2022
Figure 65 : Intertek Group Plc: Revenue Share, by Region, 2022
Figure 66 : LabCorp: Financials, 2021 and 2022
Figure 67 : LabCorp: Revenue Share, by Segment, 2022
Figure 68 : LabCorp: Revenue Share, by Region, 2022
Figure 69 : Sartorius AG: Financials, 2021 and 2022
Figure 70 : Sartorius AG: Revenue Share, by Segment, 2022
Figure 71 : Sartorius AG: Revenue Share, by Region, 2022
Figure 72 : SGS S.A.: Financials, 2021 and 2022
Figure 73 : SGS S.A.: Revenue Share, by Segment, 2022
Figure 74 : SGS S.A.: Revenue Share, by Region, 2022
Figure 75 : Syneos Health Inc.: Financials, 2021 and 2022
Figure 76 : Syneos Health Inc.: Revenue Share, by Segment, 2022
Figure 77 : WuXi AppTec Co. Ltd: Financials, 2021 and 2022
Figure 78 : WuXi AppTec Co. Ltd: Revenue Share, by Segment, 2022
Figure 79 : WuXi AppTec Co. Ltd: Revenue Share, by Region, 2022